MedChemExpress Competitors and Similar CompaniesClear all
Viracta Therapeutics's competitors and similar companies include Epsilogen and Urogen Pharma.
 Viracta Therapeutics Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients with viral-associated cancers and other serious diseases. |  Epsilogen Epsilogen (formerly IGEM Therapeutics) is an immuno-oncology company specializing in the development of IgE antibody drugs to fight cancer.
| ||
Founding Date | Founding Date 2016 | Founding Date 2017 | Founding Date 2004 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Encinitas, US HQ | Locations Reading, GB HQ London, GB | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US |
Employees | Employees 323% increase | Employees 28 | Employees 194362% increase |
Valuation ($) | Valuation ($) 8.7 m | Valuation ($) N/A | Valuation ($) 515.9 m |
Financial | |||
Net income | Net income ($51.1m) (FY, 2023) | Net income N/A | Net income ($153.5m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Epsilogen
HQ
Reading, GB
Employees
28
Epsilogen (formerly IGEM Therapeutics) is an immuno-oncology company specializing in the development of IgE antibody drugs to fight cancer.
View company
Urogen Pharma
HQ
New York, US
Employees
194
UroGen Pharma is a clinical-stage biopharmaceutical company.
View company